Everest Organics Limited (BOM:524790)
284.65
+10.95 (4.00%)
At close: Jul 7, 2026
Everest Organics Market Cap
Everest Organics has a market cap or net worth of 2.76 billion as of July 8, 2026. Its market cap has decreased by -29.28% in one year.
Market Cap
2.76B
Enterprise Value
3.26B
Revenue
1.97B
Ranking
n/a
PE Ratio
49.94
Stock Price
284.65
Market Cap Chart
Since January 4, 2002, Everest Organics's market cap has increased from 35.70M to 2.76B, an increase of 7,642.36%. That is a compound annual growth rate of 19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 2.76B | -43.72% |
| Dec 31, 2025 | 4.91B | 103.94% |
| Dec 31, 2024 | 2.41B | 137.70% |
| Dec 29, 2023 | 1.01B | 2.68% |
| Dec 30, 2022 | 986.80M | -50.48% |
| Dec 31, 2021 | 1.99B | -10.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medico Remedies | 3.40B |
| Medicamen Biotech | 3.25B |
| Trident Lifeline | 3.17B |
| BDH Industries | 2.96B |
| Astonea Labs | 2.75B |
| Gennex Laboratories | 2.49B |
| Ambalal Sarabhai Enterprises | 2.47B |
| Sat Kartar Life | 2.33B |